Difficulty: Medium
Average Score: 83%
Practice
Mineralocorticoid effects cause:
Correct answer
B
Rationale
In understanding the effects of pharmacological treatments on clients across a lifespan, it is crucial to have a comprehensive understanding of how mineralocorticoids function. Mineralocorticoids, such as aldosterone, are hormones that primarily act on the kidneys to regulate electrolyte balance and blood pressure.
Option B, "Increased Na retention and K excretion," is the correct answer. Mineralocorticoids, like aldosterone, promote the reabsorption of sodium ions and water in the distal convoluted tubules and collecting ducts of the kidneys. This results in an increase in sodium retention while promoting the excretion of potassium ions. These actions help to regulate blood volume and maintain electrolyte balance in the body.
Options A, C, and D are incorrect in the context of mineralocorticoid effects. Increased catabolism (Option A) is not directly influenced by mineralocorticoids; rather, it is more closely associated with other hormonal systems like glucocorticoids. Increased gluconeogenesis (Option C) is a function typically associated with glucocorticoids, not mineralocorticoids. Deposition of fat on shoulders, face, and abdomen (Option D) is a characteristic feature of Cushing's syndrome, which is related to excess glucocorticoid activity.
In an educational context, understanding the specific effects of mineralocorticoids is essential for healthcare professionals, especially those involved in prescribing medications that may impact these hormonal systems. By recognizing the role of mineralocorticoids in sodium and potassium balance, healthcare providers can better anticipate and manage potential side effects or therapeutic outcomes of pharmacological treatments that target these pathways.
Option B, "Increased Na retention and K excretion," is the correct answer. Mineralocorticoids, like aldosterone, promote the reabsorption of sodium ions and water in the distal convoluted tubules and collecting ducts of the kidneys. This results in an increase in sodium retention while promoting the excretion of potassium ions. These actions help to regulate blood volume and maintain electrolyte balance in the body.
Options A, C, and D are incorrect in the context of mineralocorticoid effects. Increased catabolism (Option A) is not directly influenced by mineralocorticoids; rather, it is more closely associated with other hormonal systems like glucocorticoids. Increased gluconeogenesis (Option C) is a function typically associated with glucocorticoids, not mineralocorticoids. Deposition of fat on shoulders, face, and abdomen (Option D) is a characteristic feature of Cushing's syndrome, which is related to excess glucocorticoid activity.
In an educational context, understanding the specific effects of mineralocorticoids is essential for healthcare professionals, especially those involved in prescribing medications that may impact these hormonal systems. By recognizing the role of mineralocorticoids in sodium and potassium balance, healthcare providers can better anticipate and manage potential side effects or therapeutic outcomes of pharmacological treatments that target these pathways.